Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: a population-based study.

By C. Prado, Jessica Lieffers, L. Mccargar, T. Reiman, M. Sawyer, Lisa Martin, Vickie E. Baracos. The Lancet Oncology, 2008

2,790 citations recorded by the source corpus.

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

Prevalence, risk factors and clinical implications of malnutrition in French Comprehensive Cancer Centres (2010, background): “Recently, Prado et al (2008) have suggested that 15% of obese patients have sarcopaenia, a complication associated with poorer functional status and independently predictive of mortality (HR 4.2; 95% CI (2.4–4.7)).”
A practical and precise approach to quantification of body composition in cancer patients using computed tomography images acquired during routine care. (2008, methodology): “The range of lumbar total muscle cross-sectional areas are comparable to those we recently observed in a cohort of 250 cancer patients (155.1 ± 38.6 cm2; range 79.2–271.5 cm2, Prado et al. 2008).”
Sarcopenia: European consensus on definition and diagnosis (2010, background): “In conditions such as malignancy, rheumatoid arthritis and ageing, lean bodymass is lost while fat mass may be preserved or even increased [28].”
Prognostic value of sarcopenia in adults with solid tumours: A meta-analysis and systematic review. (2016, positive): “Prado (2008) [45] RT and GI cancers Mixed 250 64 (35e88) NR 38.”
ESPEN expert group recommendations for action against cancer-related malnutrition. (2017, background): “It is now recognized that sarcopenia can occur concurrently with obesity [12, 53, 54].”